Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission.
Oct 2011 - :1432-0851 [PMID:22021066]
[Chu CS] [Boyer J] [Schullery DS] [Gimotty PA] [Gamerman V] [Bender J] [Levine BL] [Coukos G] [Rubin SC] [Morgan MA] [Vonderheide RH] [June CH]

TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
Apr 2003 - Clin. Cancer Res.; 9(4):1078-0432 [PMID:12684428]
[Schlienger K] [Chu CS] [Woo EY] [Rivers PM] [Toll AJ] [Hudson B] [Maus MV] [Riley JL] [Choi Y] [Coukos G] [Kaiser LR] [Rubin SC] [Levine BL] [Carroll RG] [June CH]